Literature DB >> 29020392

How to use Mendelian randomization to anticipate the results of randomized trials.

Brian A Ference1.   

Abstract

Mesh:

Substances:

Year:  2018        PMID: 29020392     DOI: 10.1093/eurheartj/ehx462

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  20 in total

Review 1.  Lp(a): Addressing a Target for Cardiovascular Disease Prevention.

Authors:  Nestor Vasquez; Parag H Joshi
Journal:  Curr Cardiol Rep       Date:  2019-07-31       Impact factor: 2.931

2.  Mendelian randomization reveals unexpected effects of CETP on the lipoprotein profile.

Authors:  Lisanne L Blauw; Raymond Noordam; Sebastian Soidinsalo; C Alexander Blauw; Ruifang Li-Gao; Renée de Mutsert; Jimmy F P Berbée; Yanan Wang; Diana van Heemst; Frits R Rosendaal; J Wouter Jukema; Dennis O Mook-Kanamori; Peter Würtz; Ko Willems van Dijk; Patrick C N Rensen
Journal:  Eur J Hum Genet       Date:  2018-11-12       Impact factor: 4.246

3.  Association of Triglyceride-Lowering LPL Variants and LDL-C-Lowering LDLR Variants With Risk of Coronary Heart Disease.

Authors:  Brian A Ference; John J P Kastelein; Kausik K Ray; Henry N Ginsberg; M John Chapman; Chris J Packard; Ulrich Laufs; Clare Oliver-Williams; Angela M Wood; Adam S Butterworth; Emanuele Di Angelantonio; John Danesh; Stephen J Nicholls; Deepak L Bhatt; Marc S Sabatine; Alberico L Catapano
Journal:  JAMA       Date:  2019-01-29       Impact factor: 56.272

4.  Using genetics to assess the association of commonly used antihypertensive drugs with diabetes, glycaemic traits and lipids: a trans-ancestry Mendelian randomisation study.

Authors:  Jie V Zhao; Fangchao Liu; C Mary Schooling; Jianxin Li; Dongfeng Gu; Xiangfeng Lu
Journal:  Diabetologia       Date:  2022-01-26       Impact factor: 10.122

5.  Low-Density Lipoprotein Cholesterol Attributable Cardiovascular Disease Risk Is Sex Specific.

Authors:  Arjen J Cupido; Folkert W Asselbergs; A Floriaan Schmidt; G Kees Hovingh
Journal:  J Am Heart Assoc       Date:  2022-06-14       Impact factor: 6.106

6.  Association of LPA Variants With Risk of Coronary Disease and the Implications for Lipoprotein(a)-Lowering Therapies: A Mendelian Randomization Analysis.

Authors:  Stephen Burgess; Brian A Ference; James R Staley; Daniel F Freitag; Amy M Mason; Sune F Nielsen; Peter Willeit; Robin Young; Praveen Surendran; Savita Karthikeyan; Thomas R Bolton; James E Peters; Pia R Kamstrup; Anne Tybjærg-Hansen; Marianne Benn; Anne Langsted; Peter Schnohr; Signe Vedel-Krogh; Camilla J Kobylecki; Ian Ford; Chris Packard; Stella Trompet; J Wouter Jukema; Naveed Sattar; Emanuele Di Angelantonio; Danish Saleheen; Joanna M M Howson; Børge G Nordestgaard; Adam S Butterworth; John Danesh
Journal:  JAMA Cardiol       Date:  2018-07-01       Impact factor: 14.676

7.  Evaluating the cardiovascular safety of sclerostin inhibition using evidence from meta-analysis of clinical trials and human genetics.

Authors:  Jonas Bovijn; Kristi Krebs; Chia-Yen Chen; Ruth Boxall; Jenny C Censin; Teresa Ferreira; Sara L Pulit; Craig A Glastonbury; Samantha Laber; Iona Y Millwood; Kuang Lin; Liming Li; Zhengming Chen; Lili Milani; George Davey Smith; Robin G Walters; Reedik Mägi; Benjamin M Neale; Cecilia M Lindgren; Michael V Holmes
Journal:  Sci Transl Med       Date:  2020-06-24       Impact factor: 17.956

Review 8.  Integrating genomics with biomarkers and therapeutic targets to invigorate cardiovascular drug development.

Authors:  Michael V Holmes; Tom G Richardson; Brian A Ference; Neil M Davies; George Davey Smith
Journal:  Nat Rev Cardiol       Date:  2021-03-11       Impact factor: 32.419

9.  Mendelian Randomization Study of ACLY and Cardiovascular Disease.

Authors:  Brian A Ference; Kausik K Ray; Alberico L Catapano; Thatcher B Ference; Stephen Burgess; David R Neff; Clare Oliver-Williams; Angela M Wood; Adam S Butterworth; Emanuele Di Angelantonio; John Danesh; John J P Kastelein; Stephen J Nicholls
Journal:  N Engl J Med       Date:  2019-03-14       Impact factor: 176.079

10.  Relative effects of LDL-C on ischemic stroke and coronary disease: A Mendelian randomization study.

Authors:  Elsa Valdes-Marquez; Sarah Parish; Robert Clarke; Traiani Stari; Bradford B Worrall; Jemma C Hopewell
Journal:  Neurology       Date:  2019-02-20       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.